Management

First biosimilar Trastuzumab has been recently approved by the US FDA. Kiran Mazumdar Shaw, CMD, Biocon, reveals more an in an…

Ashish Prasad, Partner, Economic Laws Practice, Indian Pharma Inc will need to take stock of the current situation and chalk out a…

Krishna Sarma, Managing Partner of Corporate Law Group, gives an insight about the need to take positive learnings from the…

As Novartis’ social business venture, Arogya Parivar completes a decade, the company prepares to plug the gaps and scale up both…

Global ill-health can render even health-secure nations vulnerable in a seamless world. An insight by Bharathi Ghanashyam, Founder…

According to GlobalData, NPWT market growth will be driven primarily by increasing awareness of the technique and its various…

The burden of diagnosed Crohn’s Disease (CD) is expected to grow between 2016 and 2026 in the seven major markets

Trends indicate that medical tourism will also bolster the demand for sophisticated devices and emerge as an important source of…

Increased market diversification is expected due to patent expiries for major insulin products

Rabindra Jhunjhunwala, Partner, Khaitan & Co and Sameer Sah, Associate Partner, Khaitan & Co share their insights on…